From its origins in 1998, when the EMST150 was tested by high school band members playing wind instruments, we have been research-focused in terms of providing validation of its benefits. That first study and dozens of subsequent studies covering diverse patient groups and respiratory-focused objectives are available on this website. As you will discover in reading these studies, the effectiveness of the EMST150 has been repeatedly and demonstrably proven in addressing diverse respiratory needs.

Aspire Respiratory Products is committed to future research and validation of the EMST150 and its other products. Only through continuing to study the effects and benefits of our products can we share these empirical results with healthcare professionals and individual consumers.


Amyotrophic Lateral Sclerosis (ALS) / Motor Neuron Disease (MND)




COVID Support




Head and Neck


Healthy Individuals


Lung Function / Exercise


Multiple Sclerosis


Parkinson’s Disease



Sleep Apnea


Spinal Cord Injury